Regulation of Cytokine-Induced Neuron Death by Ovarian Hormones: Involvement of Antiapoptotic Protein Expression and c-JUN N-Terminal Kinase-Mediated Proapoptotic Signaling

Endocrinology

Volumn 145, Issue 1, 2004, Pages 95-103

  Koski, Carol Lee ^a,b   Hila, Sorana ^a   Hoffman, Gloria E ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CYTOKINE; DEOXYURIDINE TRIPHOSPHATE DERIVATIVE; DNA NUCLEOTIDYLEXOTRANSFERASE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; PROGESTERONE; PROTEIN BCL XL; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL SELECTION; CELL STRAIN; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FLUORESCENCE; HORMONE ACTION; NERVE CELL NECROSIS; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-X PROTEIN; CASPASE 8; CASPASE 9; CASPASES; CELL SURVIVAL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASES; NERVE GROWTH FACTOR; NEURONS; PC12 CELLS; PROGESTERONE; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RECEPTORS, ESTROGEN; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0347719529     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0803     Document Type: Article

References (87)

1. Stoll G, Jander S, Schroeter M 2000 Cytokines in CNS disorders: neurotoxicity versus neuroprotection. J Neural Transm Suppl 59:81-89
2. Laabich A, Li G, Cooper NG 2001 Characterization of apoptosis-genes associated with NMDA mediated cell death in the adult rat retina. Brain Res Mol Brain Res 91:34-42
3. Laabich A, Li G, Cooper NG 2002 Enhanced expression of TNF-R1 protein in NMDA-mediated cell death in the retina. Brain Res Mol Brain Res 109:239-246
4. Yu Z, Cheng G, Wen X, Wu GD, Lee WT, Pleasure D 2002 Tumor necrosis factor Q increases neuronal vulnerability to excitotoxic necrosis by inducing expression of the AMPA-glutamate receptor subunit GluR1 via an acid sphingomyelinase- and NF-êB-dependent mechanism. Neurobiol Dis 11:199-213
5. Chaparro-Huerta V, Rivera-Cervantes MC, Torres-Mendoza BM, Beas-Zarate C 2002 Neuronal death and tumor necrosis factor-a response to glutamate-induced excitotoxidry in the cerebral cortex of neonatal rats. Neurosci Lett 333:95-98
6. Shinoda S, Skradski SL, Araki T, Schindler CK, Meller R, Lan JQ, Take W, Simon RP, Henshall DC 2003 Formation of a tumour necrosis factor receptor 1 molecular scaffolding complex and activation of apoptosis signal-regulating kinase 1 during seizure-induced neuronal death. Eur J Neurosci 17:2065-2076
7. de Bock F, Dornand J, Rondouin G 1996 Release of TNF α in the rat hippocampus following epileptic seizures and excitotoxic neuronal damage. Neuroreport 7:1125-1129
8. Zassler B, Weis C, Humpel C 2003 Tumor necrosis factor-a triggers cell death of sensitized potassium chloride-stimulated cholinergic neurons. Brain Res Mol Brain Res 113:78-85
9. Martin-Villalba A, Herr I, Jeremias I, Hahne M, Brandt R, Vogel J, Schenkel J, Herdegen T, Debatin KM 1999 CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J Neurosci 19:3809-3817
10. Martin-Villalba A, Hahne M, Kleber S, Vogel J, Falk W, Schenkel J, Krammer PH 2001 Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death Differ 8:679-686
11. Stoll G, Jander S, Schroeter M 1998 Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol 56:149-171
12. Hurtado O, Lizasoain I, Fernandez-Tome P, Alvarez-Barrentos A, Leza JC, Lorenza JC, Moro MA 2002 TACE/ADAM17-TNF-α pathway in rat cortical cultures after exposure to oxygen-glucose deprivation or glutamate. J Cereb Blood Flow Metab 22:576-585
13. Jander S, Schroeter M, Stoll G 2000 Role of NMDA receptor signaling in the regulation of inflammatory gene expression after focal brain ischemia. J Neuroimmunol 109:181-187
14. Parkinson FE, Zhang YW, Shepel PN, Greenway SC, Peeling J, Geiger JD 2000 Effects of nitrobenzylthioinosine on neuronal injury, adenosine levels, and adenosine receptor activity in rat forebrain ischemia. J Neurochem 75: 795-802
15. Xu J, Fan G, Chen S, Wu Y, Xu XM, Hsu CY 1998 Methylprednisolone inhibition of TNF-α expression and NF-kB activation after spinal cord injury in rats. Brain Res Mol Brain Res 59:135-142
16. Clarke DJ, Branton RL 2002 A role for tumor necrosis factor α in death of dopaminergic neurons following neural transplantation. Exp Neurol 176: 154-162
17. Mayne M, Ni W, Yan HJ, Xue M, Johnson JB, Del Bigio MR, Peeling J, Power C 2001 Antisense oligodeoxynucleoride inhibition of tumor necrosis factor-α expression is neuroprotective after intracerebral hemorrhage. Stroke 32: 240-248
18. de Bock F, Derijard B, Dornand J, Bockaert J, Rondouin G 1998 The neuronal death induced by endotoxic shock but not that induced by excitatory amino acids requires TNF-α. Eur J Neurosci 10:3107-3114
19. Miura Y, Misawa N, Maeda N, Inagaki Y, Tanaka Y, Ito M, Kayagaki N, Yamamoto N, Yagita H 2001 Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice. J Exp Med 193:651-660
20. Miura Y, Koyanagi Y, Mizusawa H 2003 TNF-related apoptosis-inducing ligand (TRAIL) induces neuronal apoptosis in HIV-encephalopathy. J Med Dent Sci 50:17-25
21. Miura Y, Misawa N, Kawano Y, Okada H, Inagaki Y, Yamamoto N, Itl M, Yagita H, Okumura K 2003 Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection. Proc Natl Acad Sci USA 100:2777-2782
22. Zhang L, Looney D, Taub D, Chang SC, Way D, Witte MH, Graves MC, Fiala M 1998 Cocaine opens the blood-brain barrier to HIV-1 invasion. J Neurovirol 4:619-626
23. Bogdan I, Leib SL, Bergeron M, Chow L, Tauber MG 1997 Tumor necrosis factor-α contributes to apoptosis in hippocampal neurons during experimental group B streptococcal meningitis. J Infect Dis 176:693-697
24. Kadhim H, Sebire G 2002 Immune mechanisms in the pathogenesis of cerebral palsy: implication of proinflammatory cytokines and T lymphocytes. Eur J Paediatr Neurol 6:139-142
25. Szelenyi J 2001 Cytokines and the central nervous system. Brain Res Bull 54:329-338
26. Venters HD, Tang Q, Liu Q, VanHoy RW, Dantzer R, Kelley KW 1999 A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide. Proc Natl Acad Sci USA 96:9879-9884
27. Venters HD, Dantzer R, Kelley KW 2000 Tumor necrosis factor-α induces neuronal death by silencing survival signals generated by the type I insulin-like growth factor receptor. Ann NY Acad Sci 917:210-220
28. Venters HD, Dantzer R, Kelley KW 2000 A new concept in neurodegenerarion: TNFα is a silencer of survival signals. Trends Neurosci 23:175-180
29. Bjartmar C, Yin X, Trapp BD 1999 Axonal pathology in myelin disorders. J Neurocytol 28:383-395
30. Bjartmar C, Kidd G, Mork S, Rudick R, Trapp BD 2000 Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 48:893-901
31. Lovas G, Szilagyi N, Majtenyi K, Palkovits M, Komoly S 2000 Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 123: 308-317
32. Perry VH, Anthony DC 1999 Axon damage and repair in multiple sclerosis. Philos Trans R Soc Lond B Biol Sci 354:1641-1647
33. Peterson JW, Bo L, Mork S, Chang A, Trapp BD 2001 Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 50:389-400
34. Alcazar A, Regidor I, Masjuan J, Saunas M, Alvarez-Cermeno JC 2000 Axonal damage induced by cerebrospinal fluid from patients with relapsing-remitting multiple sclerosis. J Neuroimmunol 104:58-67
35. Alcazar A, Regidor I, Masjuan J, Salinas M, Alvarez-Cermeno JC 1998 Induction of apoptosis by cerebrospinal fluid from patients with primary-progressive multiple sclerosis in cultured neurons. Neurosci Lett 255:75-78
36. Whitacre CC, Reingold SC, O'Looney PA 1999 A gender gap in autoimmunity. Science 283:1277-1278
37. Whitacre CC, Dowdell K, Griffin AC 1998 Neuroendocrine influences on experimental autoimmune encephalomyelitis. Ann NY Acad Sci 840:705-716
38. Duquette P, Girard M 1993 Hormonal factors in susceptibility to multiple sclerosis. Curr Opin Neurol Neurosurg 6:195-201
39. Runmarker B, Andersen O 1995 Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 118:253-261
40. Siiteri PK, Stites DP 1982 Immunologic and endocrine interrelationships in pregnancy. Biol Reprod 26:1-14
41. Gilmore W, Weiner LP, Correale J 1997 Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 158:446-451
42. Arnason BG, Richman DP 1969 Effects of estrogen, progestin and combined estrogen-progestin oral contraceptive preparations on experimental allergic encephalomyelitis. Trans Am Neurol Assoc 94:54-58
43. Bebo Jr BF, Fyfe-Johnson A, Adlard K, Beam AG, Vandenbark AA, Offner H 2001 Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J Immunol 166:2080-2089
44. Ito A, Bebo Jr BF, Matejuk A, Zamora A, Silverman M, Fyfe-Johnson A, Offner H 2001 Estrogen treatment down-regulates TNFα production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J Immunol 167:542-552
45. Kim S, Liva SM, Dalal MA, Verity MA, Voskuhl RR 1999 Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis. Neurology 52:1230-1238
46. Marzi M, Vigano A, Trabattoni D, Villa ML, Salvaggio A, Clerici E, Clerici M 1996 Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 106:127-133
47. Hoffman GE, Le WW, Murphy AZ, Koski CL 2001 Divergent effects of ovarian steroids on neuronal survival during experimental allergic encephalitis. Exp Neurol 171:272-284
48. Verthelyi D, Klinman DM 2000 Sex hormone levels correlate with the activity of cytokine-secreting cells in vivo. Immunology 100:384-390
49. Baker DA, Phillips CA, Roessner K, Albertini RJ, Mann LI 1980 Suppression by progesterone of nonspecific in vitro lymphocyte stimulation in mice as a mechanism for the enhancement of herpes simplex virus type 2 vaginal infection. Am J Obstet Gynecol 136:440-445
50. Borel IM, Freire SM, Rivera E, Canellada A, Binaghi RA, Margni RA 1999 Modulation of the immune response by progesterone-induced lymphocyte factors. Scand J Immunol 49:244-250
51. Caggiula AR, Stoney CM, Matthews KA, Owens JF, Davis MC, Rabin BS 1990 T-lymphocyte reactivity during the menstrual cycle in women. Clin Immunol Immunopathol 56:130-134
52. Herrera LA, Montero R, Leon-Cazares JM, Rojas E, Gonsebatt ME, Ostrosky-Wegman P 1992 Effects of progesterone and estradiol on the proliferation of phytohemagglutinin-stimulated human lymphocytes. Mutat Res 270:211-218
53. Stites DP, Bugbee S, Siiteri PK 1983 Differential actions of progesterone and cortisol on lymphocyte and monocyte interaction during lymphocyte activation - relevance to immunosuppression in pregnancy. J Reprod Immunol 5:215-228
54. Roof RL, Duvdevani R, Stein DL 1993 Gender influences outcome of brain injury: progesterone plays a protective role. Brain Res 607:333-336
55. Cordey M, Gundimeda U, Gopalakrishna R, Pike CJ 2003 Estrogen activates protein kinase C in neurons: role in neuroprotection. J Neurochem 84:1340-1348
56. Bae YH, Hwang JY, Kim YH, Koh JY 2000 Anti-oxidative neuroprotection by estrogens in mouse cortical cultures. J Korean Med Sci 15:327-336
57. Migliaccio A, Castoria G, Di Domenico M, De Falco A, Bilancio A, Auricchio F 2002 Src is an initial target of sex steroid hormone action. Ann NY Acad Sci 963:185-190
58. Singh M, Setalo Jr G, Guan X, Frail DE, Toran-Allerand CD 2000 Estrogen-induced activation of the mitogen-activated protein kinase cascade in the cerebral cortex of estrogen receptor-α knock-out mice. J Neurosci 20:1694-1700
59. Hoffman KL, Weeks JC 2001 Role of caspases and mitochondria in the steroid-induced programmed cell death of a motoneuron during metamorphosis. Dev Biol 229:517-536
60. Goswami R, Kilkus J, Scurlock B, Dawson G 2002 CrmA protects against apoptosis and ceramide formation in PC12 cells. Neurochem Res 27:735-741
61. Wallach D, Arumugam TU, Boldin MP, Cantarella G, Ganesh KA, Goncharov TM, Kovalenko AV, Rajput A, Varfolomeev EE, Zhang S 2002 How are the regulators regulated? The search for mechanisms that impose specificity on induction of cell death and NF-êB activation by members of the TNF/NGF receptor family. Arthritis Res 4(Suppl 3):S189-S196
62. Cottet S, Dupraz P, Hamburger F, Dolci W, Jaquet M, Thorens B 2002 cFLIP protein prevents tumor necrosis factor-α-mediated induction of caspase-8-dependent apoptosis in insulin-secreting betaTc-Tet cells. Diabetes 51:1805-1814
63. Kruidering M, Evan GI 2000 Caspase-8 in apoptosis: the beginning of "the end"? IUBMB Life 50:85-90
64. Mielke K, Herdegen T 2002 Fatal shift of signal transduction is an integral part of neuronal differentiation: JNKs realize TNFα-mediated apoptosis in neuronlike, but not naive, PC12 cells. Mol Cell Neurosci 20:211-224
65. Haviv R, Stein R 1999 Nerve growth factor inhibits apoptosis induced by tumor necrosis factor in PC12 cells. J Neurosci Res 55:269-277
66. Green PS, Simpkins JW 2000 Neuroprotective effects of estrogens: potential mechanisms of action. Int J Dev Neurosci 18:347-358
67. Jellinger KA, Bancher C 1998 Neuropathology of Alzheimer's disease: a critical update. J Neural Transm Suppl 54:77-95
68. Kastner P, Krust A, Turcotte B, Stropp V, Tora L, Gronemeyer H, Chambon P 1990 Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J 9:1603-1614
69. Kaushic C, Murdin AD, Underdown BJ, Wira CR 1998 Chlamydia trachomatis infection in the female reproductive tract of the rat: influence of progesterone on infectivity and immune response. Infect Immun 66:893-898
70. MacLusky NJ, Chalmers-Redman R, Kay G, Ju W, Nethrapalli IS, Tatton WG 2003 Ovarian steroids reduce apoptosis induced by trophic insufficiency in nerve growth factor-differentiated PC12 cells and axotomized rat facial motoneurons. Neuroscience 118:741-754
71. Wise PM, Dubal DB 2000 Estradiol protects against ischemic brain injury in middle-aged rats. Biol Reprod 63:982-985
72. Wilson ME, Dubal DB, Wise PM 2000 Estradiol protects against injury-induced cell death in cortical explant cultures: a role for estrogen receptors. Brain Res 873:235-242
73. Dashiell SM, Rus H, Koski CL 2000 Terminal complement complexes concomitantly stimulate proliferation and rescue of Schwann cells from apoptosis. Glia 30:187-198
74. Maundrell K, Antonsson B, Magnenat E, Camps M, Muda M, Chabert C, Gillieron C, Beschert V, Vial-Knecht E 1997 Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1. J Biol Chem 272:25238-25242
75. Mielke K, Herdegen T 2000 JNK and p38 stress kinases - degenerative effectors of signal-transduction-cascades in the nervous system. Prog Neurobiol 61:45-60
76. Wise PM, Dubal DB, Wilson ME, Rau SW, Bottner M 2001 Minireview: neuroprotective effects of estrogen - new insights into mechanisms of action. Endocrinology 142:969-973
77. Gompel A, Somai S, Chaouat M, Kazem A, Kloosterboer HJ, Beusman I, Forgez P, Mimoun M, Rostene W 2000 Hormonal regulation of apoptosis in breast cells and tissues. Steroids 65:593-598
78. Formby B, Wiley TS 1999 Bcl-2, survivin and variant CD44 v7-v10 are downregulated and p53 is upregulated in breast cancer cells by progesterone: inhibition of cell growth and induction of apoptosis. Mol Cell Biochem 202:53-61
79. Bernauer S, Wehling M, Gerdes D, Falkenstein E 2001 The human membrane progesterone receptor gene: genomic structure and promoter analysis. DNA Seq 12:13-25
80. Krippner-Heidenreich A, Tubing F, Bryde S, Willi S, Zimmermann G, Scheurich P 2002 Control of receptor-induced signaling complex formation by the kinetics of ligand/receptor interaction. J Biol Chem 277:44155-44163
81. Littlejohn AF, Tucker SJ, Mohamed AA, McKay S, Helms MJ, Vandenabeele P, MacEwan DJ 2003 Modulation by caspases of tumor necrosis factor-stimulated c-Jun N-terminal kinase activation but not nuclear factor-κB signaling. Biochem Pharmacol 65:91-99
82. Green DR 1998 Apoptotic pathways: the roads to ruin. Cell 94:695-698
83. Tang D, Lahti JM, Kidd VJ 2000 Caspase-8 activation and bid cleavage contribute to MCF7 cellular execution in a caspase-3-dependent manner during staurosporine-mediated apoptosis. J Biol Chem 275:9303-9307
84. Li H, Zhu H, Xu CJ, Yuan J 1998 Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94:491-501
85. Rapp PR, Morrison JH, Roberts JA 2003 Cyclic estrogen replacement improves cognitive function in aged ovariectomized rhesus monkeys. J Neurosci 23:5708-5714
86. Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Stefanick ML, Lane DS, Hays J 2003 Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289:2663-2672
87. Shumaker SA, Legault C, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones 3rd BN, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J 2003 Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289:2651-2662